Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of Amines, C10-14-branched and linear alkyl, [2,4-dihydro-4-[(2-hydroxy- 4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-); Amines, C10-14-branched and linearalkyl, bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-) (1:1) and Amines, C10-14-branchedand linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)] chromate(1-)
EC number: 943-144-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity study (equivalent to OECD 401) with the constituent CAS 84961-40-0: LD50 1200.0 mg/kg bw. The effect level is not corrected for the relative composition as a conservative approach.
Acute oral toxicity study (equivalent to OECD 401) with the constituent CAS 85029-57-8: LD50 > 10000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- Please refer to the attached document for the read-across justification
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 200 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Based on read-across from CAS 84961-40-0
- Remarks:
- No correction for the relative composition is applied on the effect level as a conservative approach.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 600 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Based on read-across from CAS 84961-40-0
- Remarks:
- No correction for the relative composition is applied on the effect level as a conservative approach.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 400 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Based on read-across from CAS 84961-40-0
- Remarks:
- No correction for the relative composition is applied on the effect level as a conservative approach.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 10 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Based on read-across from CAS 85029-57-8
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 200 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
No acute oral toxicity data is available on the substance itself. Therefore read-across is performed to the constituents with CAS 84961-40-0 and CAS 85029-57-8. No correction for the relative composition is applied on the effect level as a conservative approach.
CAS No. 84961-40-0
In a study equivalent to OECD Guideline 401, the acute toxicity of CAS No. 84961-40-0 was tested using male and female Sprague-Dawley rats. 5 animals/sex/dose were exposed to a single dose of 825, 1210, 1780, 2610 (only 4 males/dose) or 3830 mg/kg of test substance. Carboxymethyl cellulose (CMC) was used as vehicle. Animals were subjected to clinical observation during a period of 14 days. Clinical signs or mortality was noted at <15 min, 15 min, 30 min, 1 hour, 4 hours, 1 day, 2 days, 5 days, 6 days, 7 days, 8 days, 9 days, 12 days, 13 days and 14 days following exposure. Body weight was determined at 2-4, 7 and 13 days. All animals were subjected to pathological examination. No treatment-related effects were observed in the body weight changes. Diarrhoea and orange coloured faeces and/or urine was observed in all treated animals. Additionally, dyspnoea, apathy, stagger and a worse general condition was observed in the 2610 mg/kg dose group. No mortality was observed in the 825 mg/kg group. In the 1210 mg/kg group, 3 males and 3 females died after 7 days. In the 1780 mg/kg dose group, 1 male and 4 females died after 7 days. In the 2610 and 3830 mg/kg dose groups, all animals died after 7 days. Gross pathology only revealed findings in the animals that died during the study, which included acute dilation of the atria, acute hyperaemia and staining of the substance on organs/adipose tissue/musculature. Based on these data, an LD50 of 1600.0 and 1200.0 mg/kg was determined for males and females, respectively (BASF 1981).
CAS No. 85029-57-8
In a study equivalent to OECD Guideline 401, the acute toxicity of CAS No. 85029-57-8 was tested using male and female Gassner rats. 5 animals/sex/dose were exposed to a single dose of 8000 and 10000 mg/kg bw test substance. Carboxymethyl cellulose (CMC) was used as vehicle and the substance was administered as a watery 30% suspension. Animals were observed during a period of 14 days after 1 hour, 24 hours, 48 hours, 7 days and 14 days and necropsy of survivors was performed. No mortality was observed. Fast breathing during the first 3 hours after application. Necropsy revealed mild red staining of organs in both dose groups and 3 or 2 animals (in the 8000 and 1000 mg/kg bw dose group, respectively) had a parasite infection of the caecum (Oxyuren). Based on these data the LD50 was determined to be above 10000 mg/kg bw (BASF 1972).
Justification for classification or non-classification
Based on the results of the available studies, the substance has to be classified as Acute Tox. 4, H302 (Harmful if swallowed), in accordance with EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation No. (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.